Overcoming obstacles to repurposing for neurodegenerative disease

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer’s Drug Discovery Foundation (ADDF) and the Micha...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Shineman, Diana W, Alam, John, Anderson, Margaret, Black, Sandra E, Carman, Aaron J, Cummings, Jeffrey L, Dacks, Penny A, Dudley, Joel T, Frail, Donald E, Green, Allan, Lane, Rachel F, Lappin, Debra, Simuni, Tanya, Stefanacci, Richard G, Sherer, Todd, Fillit, Howard M
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Point of View
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184781/
https://ncbi.nlm.nih.gov/pubmed/25356422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.76
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki